Trials / Completed
CompletedNCT01291537
Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this multicentric prospective randomized controlled clinical and economic study is to investigate the effectiveness and cost-utility of long-term continuous intraduodenal infusion of levodopa ( DUODOPA), compared to best medical treatment, on advanced and severe form of Parkinson's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duodopa | |
| DRUG | best médical treatment |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2016-03-01
- First posted
- 2011-02-08
- Last updated
- 2016-10-11
Locations
20 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01291537. Inclusion in this directory is not an endorsement.